Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes

M. Padariya, A. Sznarkowska, S. Kote, M. Gómez-Herranz, S. Mikac, M. Pilch, J. Alfaro, R. Fahraeus, T. Hupp, U. Kalathiya

. 2021 ; 11 (5) : . [pub] 20210422

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Persistent link   https://www.medvik.cz/link/bmc21025837

Grant support
MAB/3/2017 Fundacja na rzecz Nauki Polskiej
2020/36/C/NZ2/00108 The National Science Centre (Narodowe Centrum Nauki; Krakow, Poland)

Interferon (IFN)-related DNA damage resistant signature (IRDS) genes are a subgroup of interferon-stimulated genes (ISGs) found upregulated in different cancer types, which promotes resistance to DNA damaging chemotherapy and radiotherapy. Along with briefly discussing IFNs and signalling in this review, we highlighted how different IRDS genes are affected by viruses. On the contrary, different strategies adopted to suppress a set of IRDS genes (STAT1, IRF7, OAS family, and BST2) to induce (chemo- and radiotherapy) sensitivity were deliberated. Significant biological pathways that comprise these genes were classified, along with their frequently associated genes (IFIT1/3, IFITM1, IRF7, ISG15, MX1/2 and OAS1/3/L). Major upstream regulators from the IRDS genes were identified, and different IFN types regulating these genes were outlined. Functional interfaces of IRDS proteins with DNA/RNA/ATP/GTP/NADP biomolecules featured a well-defined pharmacophore model for STAT1/IRF7-dsDNA and OAS1/OAS3/IFIH1-dsRNA complexes, as well as for the genes binding to GDP or NADP+. The Lys amino acid was found commonly interacting with the ATP phosphate group from OAS1/EIF2AK2/IFIH1 genes. Considering the premise that targeting IRDS genes mediated resistance offers an efficient strategy to resensitize tumour cells and enhances the outcome of anti-cancer treatment, this review can add some novel insights to the field.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025837
003      
CZ-PrNML
005      
20211026133445.0
007      
ta
008      
211013s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biom11050622 $2 doi
035    __
$a (PubMed)33922087
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Padariya, Monikaben $u International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland
245    10
$a Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes / $c M. Padariya, A. Sznarkowska, S. Kote, M. Gómez-Herranz, S. Mikac, M. Pilch, J. Alfaro, R. Fahraeus, T. Hupp, U. Kalathiya
520    9_
$a Interferon (IFN)-related DNA damage resistant signature (IRDS) genes are a subgroup of interferon-stimulated genes (ISGs) found upregulated in different cancer types, which promotes resistance to DNA damaging chemotherapy and radiotherapy. Along with briefly discussing IFNs and signalling in this review, we highlighted how different IRDS genes are affected by viruses. On the contrary, different strategies adopted to suppress a set of IRDS genes (STAT1, IRF7, OAS family, and BST2) to induce (chemo- and radiotherapy) sensitivity were deliberated. Significant biological pathways that comprise these genes were classified, along with their frequently associated genes (IFIT1/3, IFITM1, IRF7, ISG15, MX1/2 and OAS1/3/L). Major upstream regulators from the IRDS genes were identified, and different IFN types regulating these genes were outlined. Functional interfaces of IRDS proteins with DNA/RNA/ATP/GTP/NADP biomolecules featured a well-defined pharmacophore model for STAT1/IRF7-dsDNA and OAS1/OAS3/IFIH1-dsRNA complexes, as well as for the genes binding to GDP or NADP+. The Lys amino acid was found commonly interacting with the ATP phosphate group from OAS1/EIF2AK2/IFIH1 genes. Considering the premise that targeting IRDS genes mediated resistance offers an efficient strategy to resensitize tumour cells and enhances the outcome of anti-cancer treatment, this review can add some novel insights to the field.
650    _2
$a adaptorové proteiny signální transdukční $x fyziologie $7 D048868
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a poškození DNA $x genetika $x fyziologie $7 D004249
650    _2
$a chemorezistence $x genetika $x fyziologie $7 D019008
650    _2
$a lidé $7 D006801
650    _2
$a interferonový regulační faktor 7 $7 D050839
650    _2
$a interferony $x metabolismus $x fyziologie $7 D007372
650    _2
$a intracelulární signální peptidy a proteiny $7 D047908
650    _2
$a dvouvláknová RNA $7 D012330
650    _2
$a proteiny vázající RNA $7 D016601
650    _2
$a transkripční faktor STAT1 $7 D050794
650    _2
$a signální transdukce $7 D015398
650    _2
$a aktivace transkripce $7 D015533
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Sznarkowska, Alicja $u International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland
700    1_
$a Kote, Sachin $u International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland
700    1_
$a Gómez-Herranz, Maria $u International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland
700    1_
$a Mikac, Sara $u International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland
700    1_
$a Pilch, Magdalena $u International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland
700    1_
$a Alfaro, Javier $u International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland $u Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK
700    1_
$a Fahraeus, Robin $u International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, F-75010 Paris, France $u Department of Medical Biosciences, Building 6M, Umeå University, 901 85 Umeå, Sweden $u RECAMO, Masaryk Memorial Cancer Institute, Zlutykopec 7, 65653 Brno, Czech Republic
700    1_
$a Hupp, Ted $u International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland $u Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK
700    1_
$a Kalathiya, Umesh $u International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland
773    0_
$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 11, č. 5 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33922087 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133451 $b ABA008
999    __
$a ok $b bmc $g 1714751 $s 1146344
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 5 $e 20210422 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
GRA    __
$a MAB/3/2017 $p Fundacja na rzecz Nauki Polskiej
GRA    __
$a 2020/36/C/NZ2/00108 $p The National Science Centre (Narodowe Centrum Nauki; Krakow, Poland)
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Archiving options